KKR, Blackstone in race for Advent-owned Bharat Serums & Vaccines: Report
Advent had initially acquired a 74% stake in Bharat Serums for around $500 million in November 2019.
Stay updated with breaking news from Maiva Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advent had initially acquired a 74% stake in Bharat Serums for around $500 million in November 2019.
Bloomberg, citing sources, reported the transaction could be valued at as much as $1 billion.
Momentum in funding raised by private equity (PE) and venture capital (VC) picked up further this week, mainly propelled by a couple of big-ticket transactions ......
Morgan Stanley Private Equity Asia and healthcare-focused private equity firm InvAscent have jointly picked up a controlling stake in sterile injectables manufacturer Maiva Pharma Pvt. ......
Morgan Stanley Private Equity Asia and India Life Sciences have jointly acquired a controlling stake from the existing investors.